|Bid||4,352.00 x 6100|
|Ask||4,510.00 x 13000|
|Day's Range||4,443.00 - 4,497.00|
|52 Week Range||3,996.00 - 5,520.00|
|PE Ratio (TTM)||16.73|
|Dividend & Yield||2.79 (4.86%)|
|1y Target Est||N/A|
The drug would be the first such treatment in Europe.
Several big-name hedge fund investors trimmed their stakes in healthcare companies in the second quarter as the sector led the broad U.S. stock market higher, rallying amid a Republican effort to repeal and replace President Obama's signature healthcare law. Jana Partners sold all of its shares in nine healthcare companies, ranging from small-cap biotech company Acadia Pharmaceuticals Inc to health information company WebMD Health Corp to insurer Aetna Inc, according to quarterly filings released Monday.
Q2 2017 AstraZeneca PLC Earnings Call